- Home
- SSKN
as 07-26-2024 4:00pm EST
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | HORSHAM |
| Market Cap: | 11.0M | IPO Year: | 2005 |
| Target Price: | N/A | AVG Volume (30 days): | 60.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.60 - $10.80 | Next Earning Date: | 08-07-2024 |
| Revenue: | $32,545,000 | Revenue Growth: | -11.29% |
| Revenue Growth (this year): | -4.74% | Revenue Growth (next year): | 8.52% |
Stock Insider Trading Activity of Strata Skin Sciences Inc. (SSKN)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Rafaeli Dolev | SSKN | Chief Executive Officer | Jul 15 '24 | Buy | $3.14 | 19,100 | $59,974.00 | 143,156 | SEC Form 4 |
| Gov Shmuel | SSKN | COO | Dec 5 '23 | Buy | $0.44 | 14,338 | $6,308.72 | 14,338 | SEC Form 4 |
| Gov Shmuel | SSKN | COO | Dec 5 '23 | Buy | $0.45 | 562 | $252.90 | 14,900 | SEC Form 4 |
| Gov Shmuel | SSKN | COO | Dec 5 '23 | Buy | $0.46 | 300 | $138.00 | 15,200 | SEC Form 4 |
| Gov Shmuel | SSKN | COO | Dec 5 '23 | Buy | $0.47 | 4,800 | $2,256.00 | 20,000 | SEC Form 4 |
| Rubinstein Samuel | SSKN | Director | Nov 20 '23 | Sell | $0.32 | 1,000 | $320.00 | 177,602 | SEC Form 4 |
Latest Strata Skin Sciences Inc. News
SSKN Breaking Stock News: Dive into SSKN Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
STRATA Skin Sciences Completes $2.1 Million Direct Offering With Participation from Insiders
Medical Device Network
4 days ago
Strata Skin’s XTRAC Momentum 1.0 laser secures approval in Japan
MT Newswires
4 days ago
Strata Skin Sciences Secures Approval for XTRAC Momentum 1.0 Device in Japan
GlobeNewswire
4 days ago
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
MT Newswires
9 days ago
Strata Skin Sciences Insider Bought Shares Worth $723,999, According to a Recent SEC Filing
GlobeNewswire
9 days ago
STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found Safe and Effective in Study Published in Peer Reviewed Journal
GlobeNewswire
15 days ago
STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
GlobeNewswire
a month ago
STRATA Skin Sciences Sponsors Webinars Featuring Leading Dermatologists Discussing Benefits of XTRAC® and TheraClear®X Devices
Compare SSKN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SSKN Strata Skin Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.